Literature DB >> 22283365

Translational study of microRNAs and its application in kidney disease and hypertension research.

Alison J Kriegel1, Domagoj Mladinov, Mingyu Liang.   

Abstract

MicroRNA research in humans and mammalian model organisms is in a crucial stage of development. Diagnostic and therapeutic values of microRNAs appear promising, but remain to be established. The physiological and pathophysiological significance of microRNAs is generally recognized, but much better understood in some organ systems and disease areas than others. In the present paper, we review several translational studies of microRNAs, including those showing the potential value of therapeutic agents targeting microRNAs and diagnostic or prognostic microRNA markers detectable in body fluids. We discuss the lessons learned and the experience gained from these studies. Several recent studies have begun to explore translational microRNA research in kidney disease and hypertension. Translational research of microRNAs in the kidney faces unique challenges, but provides many opportunities to develop and apply new methods, and to merge complementary basic and clinical approaches.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22283365      PMCID: PMC4428581          DOI: 10.1042/CS20110159

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  82 in total

Review 1.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

2.  RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain.

Authors:  Peter T Nelson; Don A Baldwin; Wigard P Kloosterman; Sakari Kauppinen; Ronald H A Plasterk; Zissimos Mourelatos
Journal:  RNA       Date:  2005-12-22       Impact factor: 4.942

Review 3.  MicroRNA: a new entrance to the broad paradigm of systems molecular medicine.

Authors:  Mingyu Liang
Journal:  Physiol Genomics       Date:  2009-05-26       Impact factor: 3.107

4.  Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis.

Authors:  Gang Wang; Bonnie Ching-Ha Kwan; Fernand Mac-Moune Lai; Paul Cheung-Lung Choi; Kai-Ming Chow; Philip Kam-Tao Li; Cheuk-Chun Szeto
Journal:  Am J Hypertens       Date:  2009-11-12       Impact factor: 2.689

5.  E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta.

Authors:  Bo Wang; Michal Herman-Edelstein; Philip Koh; Wendy Burns; Karin Jandeleit-Dahm; Anna Watson; Moin Saleem; Gregory J Goodall; Stephen M Twigg; Mark E Cooper; Phillip Kantharidis
Journal:  Diabetes       Date:  2010-04-14       Impact factor: 9.461

6.  Microarray analysis of micro-ribonucleic acid expression in primary immunoglobulin A nephropathy.

Authors:  Yong Dai; Weiguo Sui; Huijuan Lan; Qiang Yan; He Huang; Yuanshuai Huang
Journal:  Saudi Med J       Date:  2008-10       Impact factor: 1.484

Review 7.  RNA-Seq: a revolutionary tool for transcriptomics.

Authors:  Zhong Wang; Mark Gerstein; Michael Snyder
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

Review 8.  Riboregulators in kidney development and function.

Authors:  Dwi Setyowati Karolina; E M Wintour; John Bertram; Kandiah Jeyaseelan
Journal:  Biochimie       Date:  2009-12-31       Impact factor: 4.079

9.  Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss.

Authors:  Angeles Mencía; Silvia Modamio-Høybjør; Nick Redshaw; Matías Morín; Fernando Mayo-Merino; Leticia Olavarrieta; Luis A Aguirre; Ignacio del Castillo; Karen P Steel; Tamas Dalmay; Felipe Moreno; Miguel Angel Moreno-Pelayo
Journal:  Nat Genet       Date:  2009-04-12       Impact factor: 38.330

10.  Specificity, duplex degradation and subcellular localization of antagomirs.

Authors:  Jan Krützfeldt; Satoru Kuwajima; Ravi Braich; Kallanthottathil G Rajeev; John Pena; Thomas Tuschl; Muthiah Manoharan; Markus Stoffel
Journal:  Nucleic Acids Res       Date:  2007-04-16       Impact factor: 16.971

View more
  10 in total

Review 1.  Epigenomics of hypertension.

Authors:  Mingyu Liang; Allen W Cowley; David L Mattson; Theodore A Kotchen; Yong Liu
Journal:  Semin Nephrol       Date:  2013-07       Impact factor: 5.299

Review 2.  MiR-146a/b: a family with shared seeds and different roots.

Authors:  Mark R Paterson; Alison J Kriegel
Journal:  Physiol Genomics       Date:  2017-02-17       Impact factor: 3.107

3.  Genome-wide identification of long noncoding RNAs in rat models of cardiovascular and renal disease.

Authors:  Kathirvel Gopalakrishnan; Sivarajan Kumarasamy; Blair Mell; Bina Joe
Journal:  Hypertension       Date:  2014-11-10       Impact factor: 10.190

Review 4.  Animal Models of Hypertension: A Scientific Statement From the American Heart Association.

Authors:  Lilach O Lerman; Theodore W Kurtz; Rhian M Touyz; David H Ellison; Alejandro R Chade; Steven D Crowley; David L Mattson; John J Mullins; Jeffrey Osborn; Alfonso Eirin; Jane F Reckelhoff; Costantino Iadecola; Thomas M Coffman
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

5.  MicroRNA in situ hybridization for formalin fixed kidney tissues.

Authors:  Alison J Kriegel; Mingyu Liang
Journal:  J Vis Exp       Date:  2013-11-30       Impact factor: 1.355

6.  miRNA-34a inhibits cell adhesion by targeting CD44 in human renal epithelial cells: implications for renal stone disease.

Authors:  Bohan Wang; Gaofei He; Gang Xu; Jiaming Wen; Xiao Yu
Journal:  Urolithiasis       Date:  2019-09-10       Impact factor: 3.436

Review 7.  Non-coding RNAs and hypertension-unveiling unexpected mechanisms of hypertension by the dark matter of the genome.

Authors:  Kazuo Murakami
Journal:  Curr Hypertens Rev       Date:  2015

8.  Exosomal miRNAs in urine associated with children's cardiorenal parameters: a cross-sectional study.

Authors:  Yuri Levin-Schwartz; Paul Curtin; Daniel Flores; Vasily N Aushev; Marcela Tamayo-Ortiz; Katherine Svensson; Ivan Pantic; Guadalupe Estrada-Gutierrez; María L Pizano-Zárate; Chris Gennings; Lisa M Satlin; Andrea A Baccarelli; Martha M Tellez-Rojo; Robert O Wright; Alison P Sanders
Journal:  Epigenomics       Date:  2021-02-26       Impact factor: 4.778

9.  Endogenous miR-204 Protects the Kidney against Chronic Injury in Hypertension and Diabetes.

Authors:  Yuan Cheng; Dandan Wang; Feng Wang; Jing Liu; Baorui Huang; Maria Angeles Baker; Jianyong Yin; Rui Wu; Xuanchen Liu; Kevin R Regner; Kristie Usa; Yong Liu; Congxiao Zhang; Lijin Dong; Aron M Geurts; Niansong Wang; Sheldon S Miller; Yongcheng He; Mingyu Liang
Journal:  J Am Soc Nephrol       Date:  2020-06-02       Impact factor: 14.978

10.  Concordant changes of plasma and kidney microRNA in the early stages of acute kidney injury: time course in a mouse model of bilateral renal ischemia-reperfusion.

Authors:  Melissa A Bellinger; James S Bean; Melissa A Rader; Kathleen M Heinz-Taheny; Jairo S Nunes; Joseph V Haas; Laura F Michael; Mark D Rekhter
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.